These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33641185)

  • 1. Pembrolizumab-Induced Migrating Cortico-Subcortical Brain Lesions.
    Lambert N; Steinmetz M; Sibille A; Sadzot B
    Ann Neurol; 2021 Jun; 89(6):1255-1256. PubMed ID: 33641185
    [No Abstract]   [Full Text] [Related]  

  • 2. Paraneoplastic syndrome or immune-related adverse event? A case of rhomboencephalitis in a patient treated with Pembrolizumab.
    Abbadessa G; Miele G; Fratta M; Bonavita S
    Acta Neurol Belg; 2021 Oct; 121(5):1341-1342. PubMed ID: 33393070
    [No Abstract]   [Full Text] [Related]  

  • 3. Pembrolizumab induced toxic epidermal necrolysis.
    Kumar R; Bhandari S
    Curr Probl Cancer; 2020 Apr; 44(2):100478. PubMed ID: 31122669
    [No Abstract]   [Full Text] [Related]  

  • 4. Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report.
    Yamaguchi Y; Nagasawa H; Katagiri Y; Wada M
    J Med Case Rep; 2020 Jul; 14(1):88. PubMed ID: 32620173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemophagocytic Lymphohistiocytosis in a Patient with Rheumatoid Arthritis on Pembrolizumab for Lung Adenocarcinoma.
    Akagi Y; Awano N; Inomata M; Kuse N; Tone M; Yoshimura H; Jo T; Takada K; Kumasaka T; Izumo T
    Intern Med; 2020 Apr; 59(8):1075-1080. PubMed ID: 32009093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralymphatic histiocytosis in a patient with lung adenocarcinoma treated with pembrolizumab: a case report.
    Sugano T; Seike M; Funasaka Y; Yoshida M; Takayama R; Okamura K; Nakanishi A; Tanaka T; Takeuchi S; Noro R; Minegishi Y; Kubota K; Saeki H; Gemma A
    J Immunother Cancer; 2019 Feb; 7(1):59. PubMed ID: 30813943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriatic arthritis induced by anti-programmed death 1 antibody pembrolizumab.
    Hara T; Mikita N; Ikeda T; Inaba Y; Kunimoto K; Kaminaka C; Kanazawa N; Yamamoto Y; Jinnin M
    J Dermatol; 2019 Dec; 46(12):e466-e467. PubMed ID: 31376178
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholestatic Liver Injury Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma.
    Kurokawa K; Hara M; Iwakami SI; Genda T; Iwakami N; Miyashita Y; Fujioka M; Sasaki S; Takahashi K
    Intern Med; 2019; 58(22):3283-3287. PubMed ID: 31735738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pembrolizumab-Induced Rhabdomyolysis With Myositis in a Patient With Lung Adenocarcinoma.
    Hamada S; Fuseya Y; Tsukino M
    Arch Bronconeumol (Engl Ed); 2018 Jun; 54(6):346-348. PubMed ID: 29496287
    [No Abstract]   [Full Text] [Related]  

  • 10. Retrobulbar Optic Neuritis Induced by Pembrolizumab in a Patient with Lung Adenocarcinoma.
    Kawakado K; Tamura T; Nakanishi M; Makimoto G; Kuyama S
    Intern Med; 2021 Dec; 60(24):3941-3945. PubMed ID: 34148963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pericardial tamponade during pembrolizumab treatment in a patient with advanced lung adenocarcinoma: A case report and review of the literature.
    Harada K; Ogasawara M; Shido A; Meno A; Oda S; Yoshida S; Yoshida S; Yoshikawa A; Ebata K; Abiko S; Kawagishi N; Sano I; Oda H; Miyagishima T
    Thorac Cancer; 2020 May; 11(5):1350-1353. PubMed ID: 32181993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired idiopathic generalized anhidrosis following pembrolizumab treatment.
    Furuta K; Horiguchi A; Nakagawa Y; Kambe N; Kogame T
    Clin Exp Dermatol; 2022 Feb; 47(2):463-465. PubMed ID: 34610167
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe pembrolizumab-induced gastritis in a patient with lung adenocarcinoma.
    Pérez Santamaría C; Castillo-López G; Curto García I; Gómez Iglesias P; Lumbreras Cabrera M; Carreira Guillán L
    Rev Esp Enferm Dig; 2022 Feb; 114(2):127-128. PubMed ID: 34743523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal Anti-Ma2 Encephalitis Related to Treatment of Malignant Pleural Mesothelioma With a Combination of Anti-Programmed Death 1 and Anti-Cytotoxic T-Lymphocyte Associated Protein 4 Antibodies.
    Du Rusquec P; Peyre A; Toulgoat F; Honnorat J; Raimbourg J
    J Thorac Oncol; 2019 Aug; 14(8):e174-e176. PubMed ID: 31345342
    [No Abstract]   [Full Text] [Related]  

  • 15. Bilateral Thalamic Lesions Associated With Atezolizumab-Induced Autoimmune Encephalitis.
    Nishijima H; Suzuki C; Kon T; Nakamura T; Tanaka H; Sakamoto Y; Tomiyama M
    Neurology; 2021 Jan; 96(3):126-127. PubMed ID: 33268558
    [No Abstract]   [Full Text] [Related]  

  • 16. Bilateral Vocal Cord Paralysis: Pembrolizumab-Induced Delayed-Onset Toxicity in a Patient with Lung Adenocarcinoma.
    Hamada S; Okamoto N; Tsukino M
    J Thorac Oncol; 2018 Dec; 13(12):e257-e259. PubMed ID: 30467049
    [No Abstract]   [Full Text] [Related]  

  • 17. Psuedoprogression mimicking hyperprogressive disease after pembrolizumab treatment in a patient with lung cancer.
    Hashimoto K; Kaira K; Kawasaki T; Yamaguchi O; Kagamu H
    Lung Cancer; 2020 Jan; 139():221-223. PubMed ID: 31806361
    [No Abstract]   [Full Text] [Related]  

  • 18. Pembrolizumab-Induced Seronegative Arthritis and Fasciitis in a Patient with Lung Adenocarcinoma.
    Kobak S
    Curr Drug Saf; 2019; 14(3):225-229. PubMed ID: 31132977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudoprogression and Rapid Response to Pembrolizumab in a Patient with Advanced Lung Adenocarcinoma with Loss of Epidermal Growth Factor Receptor Gene Mutation after Tyrosine Kinase Inhibitor Therapy.
    Yamaura T; Suzuki H
    J Thorac Oncol; 2018 Oct; 13(10):e209-e210. PubMed ID: 30244857
    [No Abstract]   [Full Text] [Related]  

  • 20. Life threatening pembrolizumabinduced myositis in a patient treated for advanced adenocarcinoma of the lung.
    Robinson SD; Lai C; Hotton G; Anand G
    Acute Med; 2019; 18(3):197-199. PubMed ID: 31536059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.